The Scientific Advisory Board (SAB) for The Bee Foundation provides strategic guidance and direction for the organization around research and scientific grants and programs. The SAB will play a key role in guiding and prioritizing the foundation’s diversified research investment.
The SAB is led by the chief scientific advisor who will be appointed every 2 years in October by the Board of Directors, and is comprised of leaders in neurology and similar specialties in research, clinical practice and advocacy and who have made significant contributions to advancing the field. The SAB members are committed to furthering The Bee Foundation’s mission and will each hold 2 year terms.
An estimated 6 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. The annual rate of rupture is approximately 8 per 100,000 people or about 30,000 people in the United States suffer a ruptured brain aneurysm. There is a brain aneurysm rupturing every 18 minutes.
He then attended Columbia University, College of Physicians and Surgeons, where he completed his medical degree. After finishing his internship in general surgery at New-York Presbyterian Hospital, he spent one year performing a post-doctoral research fellowship evaluating the pathophysiologic mechanisms of stroke under Drs. David Pinsky and E. Sander Connolly at Columbia University.
Pascal Jabbour, MD, is a Professor of Neurological Surgery and the Head of the Division of Neurovascular and Endovascular Neurosurgery in the Department of Neurological Surgery at the Sidney Kimmel Medical College at Thomas Jefferson University. He is a dually trained vascular neurosurgeon, performing endovascular and open procedures.
He obtained his medical degree from the University of Saskatchewan in Saskatoon, Canada, followed by Neurology residency in Vascular Neurology Fellowship at the University of Alberta in Edmonton, Canada. He then transitioned to the Cleveland Clinic and performed an Endovascular Surgical Neuroradiology fellowship.
He received his medical degree in his home state at the University of Hawaii John A. Burns School of Medicine. His training consisted of neurology residency at Yale-New Haven Hospital, a stroke fellowship at Harvard Medical School/Beth Israel Deaconess Medical Center, and an interventional neuroradiology fellowship at New York Presbyterian Hospital/Columbia College of Physicians and Surgeons.
Dr. William J Mack is the Principal Investigator and Director of the Cerebrovascular Laboratory in the Zilkha Neurogenetic Institute. He has active NIH R01 funding for his research. Dr. Mack’s scientific interests are focused on translational efforts to treat ischemic and hemorrhagic stroke. Laboratory investigations concentrate on the pathophysiology of cerebral ischemia, aneurysmal subarachnoid hemorrhage and inflammatory modulation.
